<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Wulff Harper | Activity</title>
	<link>https://brycefoster.com/members/sealace32/activity/</link>
	<atom:link href="https://brycefoster.com/members/sealace32/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Wulff Harper.</description>
	<lastBuildDate>Fri, 19 Jun 2026 15:47:12 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">a41f074b2cbe6c43b8f0c008e5fc0d93</guid>
				<title>Wulff Harper posted an update: Navigating the Cost of GLP-1 Prescriptions in Germany: A [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1520750/</link>
				<pubDate>Sun, 05 Apr 2026 12:09:08 +0000</pubDate>

									<content:encoded><![CDATA[<p>Navigating the Cost of GLP-1 Prescriptions in Germany: A Comprehensive Guide</p>
<p>The landscape of metabolic health and weight management has undergone a paradigm shift with the intro of GLP-1 (glucagon-like peptide-1) receptor agonists. In Germany, medications such as Ozempic, Wegovy, and Mounjaro have controlled health headlines, moving the&hellip;<span class="activity-read-more" id="activity-read-more-1520750"><a href="https://brycefoster.com/activity/p/1520750/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3f60bfb36ee03f925da450a72f1898e4</guid>
				<title>Wulff Harper became a registered member</title>
				<link>https://brycefoster.com/activity/p/1520673/</link>
				<pubDate>Sun, 05 Apr 2026 11:50:46 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>